发明名称 Monoclonal antibody in relation to drug-resistant cancers and production thereof.
摘要 <p>By… (a) immunizing a mouse with an adriamycin-resistant K562/ADM strain which has been established from a human myelogenous leukemia cell K562 strain (ATCC CCL243);… (b) taking spleen cells out of the immunized mouse and preparing a dispersion of the cells;… (c) subjecting the spleen cells together with mouse myeloma cells to cell fusion conditions thereby to prepare a hybridoma as a fusion product between the spleen cell and the myeloma cell;… (d) culturing the mixture of cells obtained from the step (c) on a selective medium on which only the hybridoma can grow;… (e) determining whether the hybridoma-containing supernatant of the medium contains the antibody desired thereby select hybridoma capable of producing the antibody desired;… (f) cloning the hybridoma thus selected; and… (g) incubating the clone in an abdominal cavity of a mouse or on a medium a monoclonal antibody is formed and accumulated in the cancerous ascites or the supernatant of the medium.</p>
申请公布号 EP0214640(A2) 申请公布日期 1987.03.18
申请号 EP19860112391 申请日期 1986.09.08
申请人 JAPANESE FOUNDATION FOR CANCER RESEARCH 发明人 TSURUO, TAKASHI;HAMADA, HIROFUMI;SUGANO, HARUO
分类号 G01N33/574;A61K39/395;A61K45/00;A61P35/00;C07K16/30;C12N5/10;C12N15/02;C12N15/09;C12P21/08;C12R1/91;G01N33/577 主分类号 G01N33/574
代理机构 代理人
主权项
地址